Russian development for drug independence in endocrinology: comparative analysis of bioequivalence, safety and tolerability of the first domestic liraglutide

Russian development for drug independence in endocrinology: comparative analysis of bioequivalence, safety and tolerability of the first domestic liraglutide

Liraglutide is one of the analogues of the incretin hormone human glucagon-like peptide-1 (GLP-1) and is currently a priority treatment for diseases such as type 2 diabetes mellitus (mono- and combination therapy), obesity and overweight in the presence of at least one concomitant disease.The aim of...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, S. M. Noskov
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2023-11-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
glucagon-like peptide-1
bioequivalence
pharmacokinetics
liraglutide
obesity
type 2 diabetes mellitus
enligria
Online Access:https://www.pharmpharm.ru/jour/article/view/1357
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pharmpharm.ru/jour/article/view/1357

Similar Items